Werewolf Therapeutics (HOWL)
(Delayed Data from NSDQ)
$1.49 USD
+0.04 (2.76%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.47 -0.02 (-1.34%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Werewolf Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
HOWL 1.49 +0.04(2.76%)
Will HOWL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for HOWL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HOWL
Werewolf Therapeutics, Inc. (HOWL) Just Flashed Golden Cross Signal: Do You Buy?
XOMA Royalty (XOMA) Q2 Earnings and Revenues Surpass Estimates
HOWL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates
CorMedix (CRMD) Surpasses Q2 Earnings and Revenue Estimates
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know
Other News for HOWL
180 Bullish Setup appears for HOWL after 2.76% move
Is HOWL building bullish momentum? Pocket Pivot shows up after advancing 3.57%
Bollinger Band Squeeze appears for HOWL after 3.45% move
H.C. Wainwright Sticks to Its Buy Rating for Werewolf Therapeutics (HOWL)
HOWL forms 180 Bullish Setup on September 16